Temasek

Itm and Perspective’s readouts are the latest clinical advances in GEP-NETs, the first indication to put radioligand therapies on the map

Mega-round for Alentis spotlights French firm’s investment style 

Plus: Airna, ReviR, LTZ and Synthetica draw Series A cash, while Outpace, Confo and Healx refill their coffers

Plus VC rounds for ITM Isotope, Nucleus and Vilya

Plus: ALX hires Dillon and updates from Obsidian, YS and more

The BioCentury Show: how the Singapore VC firm CEO is building a global strategy to propel the local ecosystem

The island nation has caught the interest of international investors and pharmas. Will this be the moment its biotech accelerates?

Singapore-based Sunbird hopes to roll out its exosome-based Alzheimer’s test in 2025

Plus: Mirati rises after Sanofi takeout rumor circulates, ODAC panel and updates from Kyowa Kirin, AbbVie, Evotec, FDA, Precede and more

Pharma’s JLABS unit aims to help grow ecosystem by connecting translational projects with funding, management and other resources